AFP and hepatocellular adenoma: The European Study on Glycogen Storage Disease Type I guidelines originate from 2002 and recommend screening for malignant transformation from HCA to HCC by imaging (ultrasound and MRI‐scan) and by serum alpha‐fetoprotein (AFP) and carcino‐embryonic antigen (CEA).3